Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Tetradecane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 9/20 | 0.43 |
| ▸ | CA1 | P00915 | 8/20 | 0.43 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.43 |
| ▸ | FDPS | P14324 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 4/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 6/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA3 | P07451 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL9443895 | 0.84 | SMPD1 (0.48) | TP53CA2CA1SMPD1FDPS | |
| Sulfuric Acid SCHEMBL25198201 | 0.84 | SMPD1 (0.48) | TP53CA2CA1SMPD1FDPS | |
| Sulfuric Acid SCHEMBL9443894 | 0.84 | SMPD1 (0.48) | TP53CA2CA1SMPD1FDPS | |
| Sulfuric Acid SCHEMBL25184770 | 0.84 | SMPD1 (0.48) | TP53CA2CA1SMPD1FDPS | |
| Sulfuric Acid SCHEMBL9493020 | 0.84 | SMPD1 (0.48) | TP53CA2CA1SMPD1FDPS | |
| Tetradecane SCHEMBL28202834 | 0.84 | TP53 (0.58) | TP53CA2CA1CA9CA12 | |
| Tetradecane SCHEMBL7611438 | 0.84 | TP53 (0.58) | TP53CA2CA1CA9CA12 | |
| Decane SCHEMBL13586006 | 0.84 | TSHR (0.57) | TP53CA2CA1CES1EPHX1 | |
| Dodecane SCHEMBL1939550 | 0.84 | TSHR (0.57) | TP53CA2CA1CES1EPHX1 | |
| Sulfuric Acid SCHEMBL1484174 | 0.84 | TSHR (0.57) | TP53CA2CA1CES1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070082033-A1 | Substrate containing lipids | BEIERSDORF AG (DE) | 2007-04-12 | — | — | US | claimed |
| CN-113727697-B | Hydrophilic silica/polymer blends | 陶氏环球技术有限责任公司 | 2024-06-04 | — | — | CN | disclosed |
| US-11931447-B2 | Polymer/hydrophilic silica oil blend | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-03-19 | — | — | US | disclosed |
| US-11771643-B2 | Cleansing compositions completely based on bio-renewable sources | GALAXY SURFACTANTS LTD. (IN) | 2023-10-03 | — | — | US | disclosed |
| US-20230165784-A1 | CLEANSING COMPOSITIONS COMPLETELY BASED ON BIO-RENEWABLE SOURCES | GALAXY SURFACTANTS LTD. (IN) | 2023-06-01 | — | — | US | disclosed |
| CN-115317408-A | Transparent foaming bath oil with all-natural source and preparation method thereof | 诺斯贝尔化妆品股份有限公司 | 2022-11-11 | — | — | CN | disclosed |
| US-20220160596-A1 | HYDROPHILIC SILICA/POLYMER BLEND | DOW GLOBAL TECHNOLOGIES LLC | 2022-05-26 | — | — | US | disclosed |
| US-20220142903-A1 | POLYMER/HYDROPHILIC SILICA OIL BLEND | ROHM AND HAAS COMPANY | 2022-05-12 | — | — | US | disclosed |
| CN-113727697-A | Hydrophilic silica/polymer blends | 陶氏环球技术有限责任公司 | 2021-11-30 | — | — | CN | disclosed |
| WO-2020223024-A1 | HYDROPHILIC SILICA/POLYMER BLEND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-11-05 | — | — | WO | disclosed |
| WO-2020223026-A1 | POLYMER/HYDROPHILIC SILICA OIL BLEND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-11-05 | — | — | WO | disclosed |
| EP-2082722-A2 | Foaming self-warming cosmetic preparations | Beiersdorf AG (DE) | 2009-07-29 | — | — | EP | disclosed |
| US-20070082033-A1 | Substrate containing lipids | BEIERSDORF AG (DE) | 2007-04-12 | — | — | US | disclosed |
| EP-0916334-A1 | Detergent composition | UNILEVER PLC (GB) | 1999-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11931447-B2 | Polymer/hydrophilic silica oil blend | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C9, MMS19 | TP53 220/4885CA2 4246/4885CA1 1745/4885 |
| US-20220160596-A1 | HYDROPHILIC SILICA/POLYMER BLEND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C9, CD44 | TP53 339/4885CA2 3879/4885CA1 1890/4885 |
| US-20070082033-A1 | Substrate containing lipids | LIPC, MGLL, LIPA | TP53 4708/4885CA2 3806/4885CA1 3211/4885 |
| US-20220142903-A1 | POLYMER/HYDROPHILIC SILICA OIL BLEND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C9, MMS19 | TP53 220/4885CA2 4246/4885CA1 1745/4885 |
| US-11771643-B2 | Cleansing compositions completely based on bio-renewable sources | PARG, PLIN3, PLK3 | TP53 2951/4885CA2 3100/4885CA1 4783/4885 |
| US-20230165784-A1 | CLEANSING COMPOSITIONS COMPLETELY BASED ON BIO-RENEWABLE SOURCES | PARG, PLIN3, PLK3 | TP53 2951/4885CA2 3100/4885CA1 4783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.